Panaji Journal

Exosomes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Direct Biologics, Codiak BioSciences, ExoCyte Therapeutics, Avalon GloboCare, United Therapeutics

 Breaking News
  • No posts were found

Exosomes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Direct Biologics, Codiak BioSciences, ExoCyte Therapeutics, Avalon GloboCare, United Therapeutics

April 15
00:21 2021
Exosomes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Direct Biologics, Codiak BioSciences, ExoCyte Therapeutics, Avalon GloboCare, United Therapeutics

Exosomes Pipeline

Exosomes are small membrane vesicles of endocytic origin that are secreted by most cells in culture and are created upon the fusion of the multivesicular body (MVB)—an intermediate endocytic compartment—with the plasma membrane. They are nano-sized vesicles capable of transferring DNAs, micro RNAs, non-coding RNAs, and lipids, with or without direct cell-to-cell contact, which represents a novel method of intracellular communication. MVB—a type of intraluminal vesicles (ILV’s)—buds inward into the endosomal lumen.

DelveInsight’s,Exosomes Pipeline Insight, 2021” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Exosomes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Request for free sample page: https://www.delveinsight.com/sample-request/exosomes-pipeline-insight

 

Some of Exosomes Companies:

  • Direct Biologics
  • Codiak BioSciences
  • ExoCyte Therapeutics
  • Avalon GloboCare
  • United Therapeutics Corporation
  • Capricor Therapeutics
  • Avalon GloboCare
  • Azymus Therapeutics
  • Versatope Therapeutics
  • Lamellar Biomedical
  • Celltrion
  • And Many Others

 

Request for free sample page: https://www.delveinsight.com/sample-request/exosomes-pipeline-insight

 

DelveInsight’s report covers around 50+ products under different phases of clinical development like

  • Late-stage products (Phase II and Phase II/III)
  • Mid-stage products (Phase II and Phase II/III)
  • Early-stage products (Phase I/II and Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration

 

Some of Exosomes Therapies:

  • LAMELLASOME IPF-NA
  • exoSTING
  • ET-08
  • AVA 201
  • Unexisome
  • CAP 2003
  • exoIL 12
  • AVA 203
  • AZ 001
  • VT 105
  • And Many Others

 

Request for free sample page: https://www.delveinsight.com/sample-request/exosomes-pipeline-insight

 

Table of Contents:

Introduction

Executive Summary

Exosomes: Overview

Formation

Exosomes in CNS Disease

Exosomes in Oncology

Exosomes in Other Diseases

• Advantages and disadvantages

Pipeline Therapeutics

• Comparative Analysis

Therapeutic Assessment

Exosomes – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

• Exosomes companies’ collaborations, Licensing, Acquisition -Deal Value Trends

Exosomes Collaboration Deals

Mid Stage Products (Phase I/II)

• Comparative Analysis

MPCs-derived exosomes: Cellular Biomedicine Group Ltd.

Pre-clinical and Discovery Stage Products

• Comparative Analysis

exoSTING: Codiak BioSciences

AVA 201: Avalon GloboCare

UNEX 42: United Therapeutics Corporation

CAP 2003: Capricor Therapeutics

AB 126: ArunA Biomedical

Drug profiles in the detailed report…..

Inactive Products

• Comparative Analysis

Exosomes Key Companies

Exosomes Key Products

Exosomes- Unmet Needs

Exosomes- Market Drivers and Barriers

Exosomes- Future Perspectives and Conclusion

Exosomes Analyst Views

Exosomes Key Companies

Appendix

Request for Deatiled TOC: https://www.delveinsight.com/sample-request/exosomes-pipeline-insight

 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/exosomes-pipeline-insight

Recent Posts